We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
BridgeBio Pharma
BBIO
$15.9B
| $700K | ﹤0.01% |
27,650
+1,300
| +5% | +$35.5K |
|
1002
Box
BOX
$4.66B
| $697K | ﹤0.01% |
26,353
| – | – |
|
|
GTM
1003
ZoomInfo Technologies
GTM
$1.25B
| $696K | ﹤0.01% |
54,500
+4,200
| +8% | +$58.8K |
|
1004
Agios Pharmaceuticals
AGIO
$2B
| $695K | ﹤0.01% |
16,123
+4,100
| +34% | +$148K |
|
1005
CONMED
CNMD
$1.49B
| $695K | ﹤0.01% |
10,023
+4,400
| +78% | +$321K |
|
1006
DXC Technology
DXC
$1.79B
| $695K | ﹤0.01% |
36,400
| – | – |
|
|
NSA
1007
DELISTED
National Storage Affiliates Trust
NSA
| $693K | ﹤0.01% |
16,816
+2,000
| +13% | +$75.4K |
|
1008
Shake Shack
SHAK
$2.98B
| $693K | ﹤0.01% |
7,700
| – | – |
|
1009
American States Water
AWR
$3.52B
| $688K | ﹤0.01% |
9,476
+109
| +1% | +$7.87K |
|
|
PCH
1010
DELISTED
PotlatchDeltic
PCH
| $687K | ﹤0.01% |
17,443
+4,100
| +31% | +$174K |
|
1011
Columbia Sportswear
COLM
$2.96B
| $685K | ﹤0.01% |
8,658
| – | – |
|
1012
Fox Class A
FOXA
$27.5B
| $685K | ﹤0.01% |
19,937
-3,091
| -13% | -$101K |
|
|
PPLI
1013
People Inc
PPLI
$3.01B
| $684K | ﹤0.01% |
17,797
+3,291
| +23% | +$136K |
|
1014
Guardant Health
GH
$21.4B
| $683K | ﹤0.01% |
23,641
-208,700
| -90% | -$4.86M |
|
1015
International Bancshares
IBOC
$4.57B
| $681K | ﹤0.01% |
11,902
-1,100
| -8% | -$61.9K |
|
1016
Hilton Grand Vacations
HGV
$3.49B
| $680K | ﹤0.01% |
16,809
| – | – |
|
1017
PTC Therapeutics
PTCT
$6.01B
| $679K | ﹤0.01% |
22,200
-5,100
| -19% | -$165K |
|
1018
Amphastar Pharmaceuticals
AMPH
$858M
| $676K | ﹤0.01% |
16,900
+2,800
| +20% | +$116K |
|
1019
Acuity Brands
AYI
$10.8B
| $676K | ﹤0.01% |
2,800
-3,000
| -52% | -$767K |
|
1020
CleanSpark
CLSK
$2.96B
| $675K | ﹤0.01% |
+42,300
| New | +$711K |
|
1021
Spectrum Brands
SPB
$2.09B
| $674K | ﹤0.01% |
7,843
-300
| -4% | -$26.1K |
|
1022
WD-40
WDFC
$3.09B
| $673K | ﹤0.01% |
3,065
+500
| +19% | +$116K |
|
1023
First Hawaiian
FHB
$3.39B
| $671K | ﹤0.01% |
32,309
+3,500
| +12% | +$73.5K |
|
1024
Tanger
SKT
$4.42B
| $671K | ﹤0.01% |
24,753
+2,100
| +9% | +$57.8K |
|
1025
Resideo Technologies
REZI
$3.1B
| $669K | ﹤0.01% |
34,200
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.